BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36219681)

  • 1. Endometriosis-Associated Mesenchymal Stem Cells Support Ovarian Clear Cell Carcinoma through Iron Regulation.
    Atiya HI; Frisbie L; Goldfeld E; Orellana T; Donnellan N; Modugno F; Calderon M; Watkins S; Zhang R; Elishaev E; Soong TR; Vlad A; Coffman L
    Cancer Res; 2022 Dec; 82(24):4680-4693. PubMed ID: 36219681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteine Deprivation Targets Ovarian Clear Cell Carcinoma
    Novera W; Lee ZW; Nin DS; Dai MZ; Binte Idres S; Wu H; Damen JMA; Tan TZ; Sim AYL; Long YC; Wu W; Huang RY; Deng LW
    Antioxid Redox Signal; 2020 Dec; 33(17):1191-1208. PubMed ID: 32336105
    [No Abstract]   [Full Text] [Related]  

  • 3. Transcriptomic analyses of ovarian clear-cell carcinoma with concurrent endometriosis.
    Collins KE; Wang X; Klymenko Y; Davis NB; Martinez MC; Zhang C; So K; Buechlein A; Rusch DB; Creighton CJ; Hawkins SM
    Front Endocrinol (Lausanne); 2023; 14():1162786. PubMed ID: 37621654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the presence of endometriosis associated with a survival benefit in pure ovarian clear cell carcinoma?
    Sahin H; Sari ME; Cuylan ZF; Haberal AN; Sirvan L; Coban G; Yalcin I; Güngör T; Celik H; Meydanli MM; Ayhan A
    Arch Gynecol Obstet; 2018 Apr; 297(4):1005-1013. PubMed ID: 29383437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular changes in endometriosis-associated ovarian clear cell carcinoma.
    Worley MJ; Liu S; Hua Y; Kwok JS; Samuel A; Hou L; Shoni M; Lu S; Sandberg EM; Keryan A; Wu D; Ng SK; Kuo WP; Parra-Herran CE; Tsui SK; Welch W; Crum C; Berkowitz RS; Ng SW
    Eur J Cancer; 2015 Sep; 51(13):1831-42. PubMed ID: 26059197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron overload increases the sensitivity of endometriosis stromal cells to ferroptosis via a PRC2-independent function of EZH2.
    Luo Y; Li L; Hu Q; Zhang Z; Liu F; Peng Y; Zou Y; Chen L
    Int J Biochem Cell Biol; 2024 Apr; 169():106553. PubMed ID: 38417568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte nuclear factor-1β (HNF-1β) promotes glucose uptake and glycolytic activity in ovarian clear cell carcinoma.
    Okamoto T; Mandai M; Matsumura N; Yamaguchi K; Kondoh H; Amano Y; Baba T; Hamanishi J; Abiko K; Kosaka K; Murphy SK; Mori S; Konishi I
    Mol Carcinog; 2015 Jan; 54(1):35-49. PubMed ID: 24105991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and significance of ARID1A mRNA in endometriosis- associated ovarian cancer.
    Wang Q; Wang L; L Y; Ding X; Liu A
    J BUON; 2017; 22(5):1314-1321. PubMed ID: 29135119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of iASPP on chemoresistance through PLK1 and autophagy in ovarian clear cell carcinoma.
    Chan KK; Wong OG; Wong ES; Chan KK; Ip PP; Tse KY; Cheung AN
    Int J Cancer; 2018 Sep; 143(6):1456-1469. PubMed ID: 29663364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometriosis does not confer improved prognosis in ovarian clear cell carcinoma: a retrospective study at a single institute.
    Zhao T; Shao Y; Liu Y; Wang X; Guan L; Lu Y
    J Ovarian Res; 2018 Jun; 11(1):53. PubMed ID: 29941051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of protease-activated receptor-2 (PAR-2) is related to advanced clinical stage and adverse prognosis in ovarian clear cell carcinoma.
    Aman M; Ohishi Y; Imamura H; Shinozaki T; Yasutake N; Kato K; Oda Y
    Hum Pathol; 2017 Jun; 64():156-163. PubMed ID: 28438620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes.
    Yamaguchi K; Mandai M; Oura T; Matsumura N; Hamanishi J; Baba T; Matsui S; Murphy SK; Konishi I
    Oncogene; 2010 Mar; 29(12):1741-52. PubMed ID: 20062075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erastin induces ferroptosis via ferroportin-mediated iron accumulation in endometriosis.
    Li Y; Zeng X; Lu D; Yin M; Shan M; Gao Y
    Hum Reprod; 2021 Mar; 36(4):951-964. PubMed ID: 33378529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetraspanin 1 promotes endometriosis leading to ovarian clear cell carcinoma.
    Shin HY; Yang W; Chay DB; Lee EJ; Chung JY; Kim HS; Kim JH
    Mol Oncol; 2021 Apr; 15(4):987-1004. PubMed ID: 33331115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2018 Jan; 28(1):11-18. PubMed ID: 28930811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Friend or foe? The prognostic role of endometriosis in women with clear cell ovarian carcinoma. A UK population-based cohort study.
    Tranoulis A; Buruiana FH; Gupta B; Kwong A; Lakhiani A; Yap J; Balega J; Singh K
    Arch Gynecol Obstet; 2022 May; 305(5):1279-1289. PubMed ID: 34468823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic landscape of ovarian clear cell carcinoma via whole exome sequencing.
    Kim SI; Lee JW; Lee M; Kim HS; Chung HH; Kim JW; Park NH; Song YS; Seo JS
    Gynecol Oncol; 2018 Feb; 148(2):375-382. PubMed ID: 29233531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting FXYD2 by cardiac glycosides potently blocks tumor growth in ovarian clear cell carcinoma.
    Hsu IL; Chou CY; Wu YY; Wu JE; Liang CH; Tsai YT; Ke JY; Chen YL; Hsu KF; Hong TM
    Oncotarget; 2016 Sep; 7(39):62925-62938. PubMed ID: 26910837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of alpha1-antitrypsin isoforms in patients with ovarian clear cell carcinoma: An exploratory study.
    Chen SY; Chang TC; Lin CY; Lai CH; Wu RC; Yang LY; Chang WY; Lee YS; Yang WV; Chao A
    J Chin Med Assoc; 2021 Nov; 84(11):1048-1053. PubMed ID: 34747901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes.
    Tan TZ; Ye J; Yee CV; Lim D; Ngoi NYL; Tan DSP; Huang RY
    EBioMedicine; 2019 Dec; 50():203-210. PubMed ID: 31761620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.